Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:AST NYSE:ETX NYSE:IFN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsETXEaton Vance Municipal Income 2028 Term Trust$19.16+0.1%$19.04$17.48▼$20.00N/AN/A21,495 shs34,592 shsIFNIndia Fund$15.05-0.9%$15.07$13.76▼$18.54$471.43M0.69181,482 shs423,861 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTAsterias Biotherapeutics0.00%0.00%0.00%0.00%0.00%ETXEaton Vance Municipal Income 2028 Term Trust-0.02%-0.21%-1.08%+5.86%+1.64%IFNIndia Fund-0.89%+2.73%-0.17%-6.17%-18.87%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsETXEaton Vance Municipal Income 2028 Term Trust$19.16+0.1%$19.04$17.48▼$20.00N/AN/A21,495 shs34,592 shsIFNIndia Fund$15.05-0.9%$15.07$13.76▼$18.54$471.43M0.69181,482 shs423,861 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTAsterias Biotherapeutics0.00%0.00%0.00%0.00%0.00%ETXEaton Vance Municipal Income 2028 Term Trust-0.02%-0.21%-1.08%+5.86%+1.64%IFNIndia Fund-0.89%+2.73%-0.17%-6.17%-18.87%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTAsterias Biotherapeutics 0.00N/AN/AN/AETXEaton Vance Municipal Income 2028 Term Trust 0.00N/AN/AN/AIFNIndia Fund 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AETXEaton Vance Municipal Income 2028 Term Trust$6.80MN/AN/AN/AN/AN/AIFNIndia FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTAsterias BiotherapeuticsN/AN/A0.00∞N/AN/AN/AN/AN/AETXEaton Vance Municipal Income 2028 Term TrustN/AN/A0.00∞N/AN/AN/AN/AN/AIFNIndia FundN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AETXEaton Vance Municipal Income 2028 Term Trust$0.462.40%N/AN/AN/AIFNIndia Fund$1.8011.96%N/AN/AN/ALatest AST, IFN, SYS, and ETX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date10/1/2025ETXEaton Vance Municipal Income 2028 Term Trustmonthly$0.07824.9%10/15/202510/15/202510/31/20259/2/2025ETXEaton Vance Municipal Income 2028 Term Trustmonthly$0.07824.92%9/15/20259/15/20259/30/20258/11/2025IFNIndia Fundquarterly$0.4312%8/22/20258/22/20259/30/20258/1/2025ETXEaton Vance Municipal Income 2028 Term Trustmonthly$0.07825.2%8/15/20258/15/20258/29/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTAsterias BiotherapeuticsN/AETXEaton Vance Municipal Income 2028 Term TrustN/AIFNIndia Fund10.76%Insider OwnershipCompanyInsider OwnershipASTAsterias BiotherapeuticsN/AETXEaton Vance Municipal Income 2028 Term TrustN/AIFNIndia FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASTAsterias BiotherapeuticsN/A55.66 millionN/ANot OptionableETXEaton Vance Municipal Income 2028 Term Trust35N/AN/ANot OptionableIFNIndia Fund21,00031.06 millionN/ANot OptionableAST, IFN, SYS, and ETX HeadlinesRecent News About These CompaniesBaron India FundOctober 21 at 12:14 PM | money.usnews.comIFN: Still A Buy, But With CaveatsOctober 20 at 9:08 AM | seekingalpha.comMutual Fund Growth Reveals Deep Divide in Indian Investment LandscapeOctober 17, 2025 | msn.comPettinga Financial Advisors LLC Reduces Position in India Fund, Inc. $IFNOctober 16, 2025 | marketbeat.comIndia's equity MF inflows ease in September; SIP and gold, silver ETFs hit record highsOctober 10, 2025 | msn.comIndia's gold ETFs hit record $10 billion AUM on biggest-ever September inflowOctober 8, 2025 | msn.comLG Electronics India's IPO draws Norway, Singapore wealth funds as anchor investorsOctober 7, 2025 | msn.comLG’s India IPO is said to attract Abu Dhabi, Norway, Singapore wealth fundsOctober 6, 2025 | msn.comIndia Fund (NYSE:IFN) Share Price Passes Below 200-Day Moving Average - What's Next?October 1, 2025 | marketbeat.comIndia Fund (NYSE:IFN) Stock Crosses Below Two Hundred Day Moving Average - Time to Sell?September 23, 2025 | marketbeat.comL Catterton hits $200 first close for India FundSeptember 15, 2025 | agriinvestor.comATrump tariffs: With key sectors insulated, mutual funds stay bullish on India's growth storySeptember 14, 2025 | msn.comIndia's equity mutual fund flows off record high as investors shift to goldSeptember 10, 2025 | msn.comL Catterton's India Fund Marks First Close at USD 200 MnSeptember 8, 2025 | msn.comIndia’s Investors, Defying Tariffs, Keep Pouring Money Into StocksSeptember 8, 2025 | nytimes.comIndia’s Mutual Fund Industry Hits Record ₹75 Lakh Crore | SEBI Chief On What’s NextAugust 22, 2025 | msn.comIndia Stock Funds Got Record $5 Billion Flows Amid July SelloffAugust 12, 2025 | bloomberg.comIIF: India May Boom, But Valuation Leaves No Margin For ErrorJuly 22, 2025 | seekingalpha.comIFN: This Is Likely Not The Time To Buy Into Indian EquitiesJuly 21, 2025 | seekingalpha.comThe India Fund, Inc. (IFN) - Yahoo FinanceJuly 18, 2025 | finance.yahoo.comNYSE:IFN Financials | India Closed Fund - Investing.comJuly 2, 2025 | investing.comMedia Sentiment Over Time Top HeadlinesView All HeadlinesGameStop Partying Like It’s 2021: What’s Behind Its 2025 Rebound?By Dan Schmidt | September 22, 20253 Small Caps That Insiders Are Buying By Thomas Hughes | September 22, 2025Which National Chains Do People Wish Were in Their State? [2025 Survey]By MarketBeat Staff | September 30, 2025Is Super Micro Next in Line for a Big AI Takeover?By Gabriel Osorio-Mazilli | September 23, 20253 Rare Earth Stocks Powering America’s Critical Minerals BoomBy Ryan Hasson | October 16, 2025AST, IFN, SYS, and ETX Company DescriptionsAsterias Biotherapeutics NYSEAMERICAN:AST$0.0020 0.00 (0.00%) As of 07/10/2019Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.Eaton Vance Municipal Income 2028 Term Trust NYSE:ETX$19.16 +0.02 (+0.10%) Closing price 10/21/2025 03:55 PM EasternExtended Trading$19.15 -0.01 (-0.05%) As of 10/21/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Eaton Vance Municipal Income 2028 Term Trust is a closed ended fixed income mutual fund launched and managed by Eaton Vance Management. It invests in the fixed income markets. The fund invest in stocks of companies operating across the diversified sectors. It was previously known as Eaton Vance Municipal Income Term Trust. Eaton Vance Municipal Income 2028 Term Trust was formed on March 28, 2013 and is domiciled in the United States.India Fund NYSE:IFN$15.05 -0.13 (-0.86%) Closing price 10/21/2025 03:59 PM EasternExtended Trading$15.05 0.00 (0.00%) As of 10/21/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The India Fund, Inc. is a close ended equity mutual fund launched and managed by Aberdeen Standard Investments (Asia) Limited. The fund invests in public equity markets of India. It seeks to invest in stocks of small-cap, mid-cap, and large-cap companies. The fund employs a quantitative and fundamental analysis with a bottom-up stock picking and asset allocation approach to create its portfolio. It benchmarks the performance of its portfolio against the IFC Investable India Index. The India Fund, Inc. was formed on December 27, 1993 and is domiciled in the Singapore. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Micron Stock Could Soar 35% on AI Memory Demand WesBanco Insiders Signal Confidence With Coordinated Buys Will D-Wave's European Expansion Keep Fueling the Rally? Navitas Soars 78% on NVIDIA Update: Is This Rally Sustainable? Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet Waymo’s Global Expansion Strengthens the Case for GOOGL Stock Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Meta vs OpenAI: Is Sora a True Threat to Meta's Dominance? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
